ExploreWatchlistsPricing
  1. US-listed companies
  2. GlobeStar Therapeutics Corp
  3. Financials
  4. Net income

GlobeStar Therapeutics Corp (GSTC)

Market cap
$124.11K
P/E ratio
SummaryFinancials
Period EndNet income (Million USD)YoY (%)
Sep 30, 2023-2+31.01%
Sep 30, 2022-1-84.82%
Sep 30, 2021-10+1709.32%
Sep 30, 2020-1-19.75%
Sep 30, 2019-1-17.35%
Sep 30, 2018-1-51.38%
Sep 30, 2017-2-52.03%
Sep 30, 2016-4+6372.61%
Sep 30, 2011-0

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat